CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Geuder Pre-Loaded Glass Cannula
      • Ampho B
      • PKP
      • ALK
      • FLAK
      • Non-Sterile Sclera
    • Reimbursement Assistance
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Sterile Tissue
    • VisionGraft
      • Glaucoma
      • Cornea
    • Sclera
    • Adverse Reaction Reporting
    • Reimbursement
    • Regulatory Information
  • Products
    • Corneal Products
      • EndoSerter-PL
      • EndoSerter
      • Cannula
      • Geuder Pre-Loaded Glass Cannula
      • Donor Punch
      • Recipient Trephine
      • Intacs
    • Products Overview
  • Innovation
  • Education
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Our Locations
    • Gift of Sight
    • DE+I
    • Careers
    • Core Commitments
    • News & Events
Request Tissue Contact Us
Patrick Lally

Patrick Lally

April 12, 2022

Patrick Lally is a partner at Petrichor Healthcare Capital Management, a life sciences-focused investment firm. Prior to joining Petrichor, Mr. Lally was a vice president at OrbiMed Advisors in their healthcare special situations and structured finance practice. Before OrbiMed, Mr. Lally was a healthcare investor in the Drawbridge Special Opportunities Fund at Fortress Investment Group. Mr. Lally holds an M.B.A. from The Wharton School at the University of Pennsylvania and an A.B. in Molecular Biology from Princeton University.

Recent Articles

  • CorneaGen Recognized With Cigna Healthy Workforce Designation

    CorneaGen Recognized With Cigna Healthy Workforce Designation

    Cigna has selected CorneaGen as a recipient of their Bronze...

    READ MORE
  • Bernie’s Quarterly Update – March 2023

    Bernie’s Quarterly Update – March 2023

    We’re already nearing the end of the first quarter, having...

    READ MORE
  • Bernie’s Quarterly Update – December 2022

    Bernie’s Quarterly Update – December 2022

    As we near the end of a very strong quarter...

    READ MORE
  • Bernie’s Quarterly Update – September 2022

    Bernie’s Quarterly Update – September 2022

    We approach the end of another great quarter and exciting...

    READ MORE
Navigation
  • Corneal Tissue
  • Products
  • Innovation
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Terms and conditions
  • Regulatory Information
Connect
  • Contact Us
CorneaGen

©2023 CorneaGen

CorneaGen